Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13097-01-3

Post Buying Request

13097-01-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13097-01-3 Usage

General Description

3-PHENYL-1H-INDAZOLE is a chemical compound with the molecular formula C14H11N. It is classified as an indazole derivative, featuring a phenyl group attached to the 3-position of the indazole ring. 3-PHENYL-1H-INDAZOLE is used as a building block in organic synthesis and pharmaceutical research. It exhibits potential bioactivity and has been studied for its potential application in the development of new drugs. The compound may also have other industrial applications such as in the production of dyes and pigments. Overall, 3-PHENYL-1H-INDAZOLE is a versatile chemical compound with various potential uses in research and industry.

Check Digit Verification of cas no

The CAS Registry Mumber 13097-01-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,9 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13097-01:
(7*1)+(6*3)+(5*0)+(4*9)+(3*7)+(2*0)+(1*1)=83
83 % 10 = 3
So 13097-01-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H10N2/c1-2-6-10(7-3-1)13-11-8-4-5-9-12(11)14-15-13/h1-9H,(H,14,15)

13097-01-3Relevant articles and documents

Polymorphism vs. desmotropy: The cases of 3-phenyl- and 5-phenyl-1H-pyrazoles and 3-phenyl-1H-indazole

Garcia, Maria Angeles,Lopez, Concepcion,Claramunt, Rosa M.,Kenz, Ahmed,Pierrot, Marcel,Elguero, Jose

, p. 2763 - 2776 (2002)

Two desmotropes, 3-phenyl-1H-pyrazole (1a) and 5-phenyl-1H-pyrazole (1b) have been isolated and the conditions for their interconversion established. The X-ray structure of 1b has been determined (a = 10.862(1), b = 5.7620(5), c = 12.927(2) A, β = 111.435

A novel and efficient synthesis of 3-aryl and 3-heteroaryl substituted-1H-indazoles and their Mannich derivatives

Servi, Sueleyman,Akguen, Z. Ruestem

, p. 3399 - 3405 (2002)

A general and highly convenient procedure for the synthesis of 3-heteroaryl and 3-aryl substituted-1H-indazoles has been developed. These compounds (3a-f) were synthesized in good yield by refluxing the NaHSO3 adduct of heteroaromatic and aromatic aldehyde and phenyl hydrazine in DMF. This procedure is more general and shorter than earlier methods. Five new 3-hetero-aryl substituted-1H-indazoles were synthesized and characterized. New Mannich derivatives of 3-(1H-pyrrol-2-yl)-1H-indazole (3a) and 3-(1H-indol-3-yl)-1H-indazole (3b) were prepared from morpholine and formaldehyde.

Synthesis of highly branched oligoethylenes by air-stable N,N-indazole derivate methallyl Ni(II) complexes

Araya, Claudia,Correa, Sebastián A.,Daniliuc, Constantin G.,Martínez-díaz, Iván,Rojas, René S.

, (2020)

Two new neutral N,N-indazole ligands bearing the carbonitrile functional group (L1 and L2) and two new air-stable cationic nickel methallyl complexes (C1 and C2) were prepared. These compounds were fully characterized by NMR, FT-IR and elemental analysis.

Synthesis, characterization and biological evaluation of benzimidazole and benzindazole derivatives as anti-hypertensive agents

Silky, Sethy,Mandal, Sudip Kumar,Ewies, Ewies Fawzy,Neerupma, Dhiman,Arun, Garg

, p. 3659 - 3664 (2021/07/10)

A substituted benzimidazole and benzindazole derivatives had been synthesized having antihypertensive activity through antagonizing the angiotensin II (Ang II) receptors. The in vivo antihypertensive activity of the compounds was done with acute renal hypertension model. Two compounds TG 1 and TG 3 were found to have antihypertensive activity comparable to Telmisartan which is a prototype for Angiotensin II receptor antagonists class of drugs.In an antihypertensive study the compounds TG 1, TG 2 and TG 3 had systolic blood pressures of 147.2 mm/Hg, 168.2 mm/Hg, and 126.3 mm/Hg, respectively. This systolic blood pressure was lower than the disease control vehicle-treated rodents, which had a systolic blood pressure of 167.2 mm/Hg. The diastolic blood pressure was 119.7 mm/Hg, 124.7 mm/Hg and 88.83 mm/Hg, respectively and that of the disease control vehicle-treated rodents was 122.3 mm/Hg. TG 3 had comparable decrease in the MABP to Telmisartan. These encouraging results make compound TG 3 effective anti-hypertensive drug candidate and worthy of further investigation.

Regioselective N-alkylation of the 1H-indazole scaffold; ring substituent and N-alkylating reagent effects on regioisomeric distribution

Alam, Ryan M.,Keating, John J.

supporting information, p. 1939 - 1951 (2021/08/23)

The indazole scaffold represents a promising pharmacophore, commonly incorporated in a variety of therapeutic drugs. Although indazole-containing drugs are frequently marketed as the corresponding N-alkyl 1H- or 2H-indazole derivative, the efficient synthesis and isolation of the desired N-1 or N-2 alkylindazole regioisomer can often be challenging and adversely affect product yield. Thus, as part of a broader study focusing on the synthesis of bioactive indazole derivatives, we aimed to develop a regioselective protocol for the synthesis of N-1 alkylindazoles. Initial screening of various conditions revealed that the combination of sodium hydride (NaH) in tetrahydrofuran (THF) (in the presence of an alkyl bromide), represented a promising system for N-1 selective indazole alkylation. For example, among fourteen C-3 substituted indazoles examined, we observed > 99% N-1 regioselectivity for 3-carboxymethyl, 3-tert-butyl, 3-COMe, and 3-carboxamide indazoles. Further extension of this optimized (NaH in THF) protocol to various C-3, -4, -5, -6, and -7 substituted indazoles has highlighted the impact of steric and electronic effects on N-1/N-2 regioisomeric distribution. For example, employing C-7 NO2 or CO2Me substituted indazoles conferred excellent N-2 regioselectivity (≥ 96%). Importantly, we show that this optimized N-alkylation procedure tolerates a wide structural variety of alkylating reagents, including primary alkyl halide and secondary alkyl tosylate electrophiles, while maintaining a high degree of N-1 regioselectivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13097-01-3